These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21633525)
1. Mallory-Denk Bodies in chronic hepatitis. Basaranoglu M; Turhan N; Sonsuz A; Basaranoglu G World J Gastroenterol; 2011 May; 17(17):2172-7. PubMed ID: 21633525 [TBL] [Abstract][Full Text] [Related]
2. Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin. Kayaçetin S; Başaranoğlu M Turk J Gastroenterol; 2015 Nov; 26(6):506-10. PubMed ID: 26507848 [TBL] [Abstract][Full Text] [Related]
3. TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. Liu H; Li J; Tillman B; Morgan TR; French BA; French SW Exp Mol Pathol; 2014 Oct; 97(2):234-40. PubMed ID: 24997224 [TBL] [Abstract][Full Text] [Related]
4. The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation. French BA; Oliva J; Bardag-Gorce F; French SW Exp Mol Pathol; 2011 Jun; 90(3):252-6. PubMed ID: 21256843 [TBL] [Abstract][Full Text] [Related]
5. Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH). Liu H; Gong M; French BA; Li J; Tillman B; French SW Exp Mol Pathol; 2014 Dec; 97(3):477-83. PubMed ID: 25290169 [TBL] [Abstract][Full Text] [Related]
6. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [TBL] [Abstract][Full Text] [Related]
7. From Mallory to Mallory-Denk bodies: what, how and why? Zatloukal K; French SW; Stumptner C; Strnad P; Harada M; Toivola DM; Cadrin M; Omary MB Exp Cell Res; 2007 Jun; 313(10):2033-49. PubMed ID: 17531973 [TBL] [Abstract][Full Text] [Related]
8. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. Liu H; Li J; Tillman B; French BA; French SW Exp Mol Pathol; 2014 Aug; 97(1):81-8. PubMed ID: 24893112 [TBL] [Abstract][Full Text] [Related]
9. Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Rakoski MO; Brown MB; Fontana RJ; Bonkovsky HL; Brunt EM; Goodman ZD; Lok AS; Omary MB; Clin Gastroenterol Hepatol; 2011 Oct; 9(10):902-909.e1. PubMed ID: 21782771 [TBL] [Abstract][Full Text] [Related]
10. Mallory-Denk bodies and hepatocellular senescence: a causal relationship? Denk H; Abuja PM; Zatloukal K Virchows Arch; 2024 Apr; 484(4):637-644. PubMed ID: 38289501 [TBL] [Abstract][Full Text] [Related]
11. Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation. Robin MA; Descatoire V; Pessayre D; Berson A Toxicol In Vitro; 2008 Sep; 22(6):1511-9. PubMed ID: 18603402 [TBL] [Abstract][Full Text] [Related]
12. Alleviation mechanisms against hepatocyte oxidative stress in patients with chronic hepatic disorders. Hiura M; Honma Y; Miyagawa K; Oe S; Shimajiri S; Mihara H; Oe M; Sato-Morita M; Katsuki Y; Harada M Hepatol Res; 2015 Nov; 45(11):1124-35. PubMed ID: 25581125 [TBL] [Abstract][Full Text] [Related]
13. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hanada S; Strnad P; Brunt EM; Omary MB Hepatology; 2008 Sep; 48(3):943-52. PubMed ID: 18697208 [TBL] [Abstract][Full Text] [Related]
14. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis. Uraz S; Aygun C; Sonsuz A; Ozbay G Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776 [TBL] [Abstract][Full Text] [Related]
15. Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions. Mahajan V; Klingstedt T; Simon R; Nilsson KP; Thueringer A; Kashofer K; Haybaeck J; Denk H; Abuja PM; Zatloukal K Gastroenterology; 2011 Sep; 141(3):1080-1090.e1-7. PubMed ID: 21699779 [TBL] [Abstract][Full Text] [Related]
16. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Hanada S; Snider NT; Brunt EM; Hollenberg PF; Omary MB Gastroenterology; 2010 Apr; 138(4):1607-17. PubMed ID: 20064513 [TBL] [Abstract][Full Text] [Related]
17. Histopathology, grading and staging of nonalcoholic fatty liver disease. Kleiner DE Minerva Gastroenterol Dietol; 2018 Mar; 64(1):28-38. PubMed ID: 28948754 [TBL] [Abstract][Full Text] [Related]
18. High-fat diet triggers Mallory-Denk body formation through misfolding and crosslinking of excess keratin 8. Kucukoglu O; Guldiken N; Chen Y; Usachov V; El-Heliebi A; Haybaeck J; Denk H; Trautwein C; Strnad P Hepatology; 2014 Jul; 60(1):169-78. PubMed ID: 24519272 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis. Aigelsreiter A; Neumann J; Pichler M; Halasz J; Zatloukal K; Berghold A; Douschan P; Rainer F; Stauber R; Haybaeck J; Denk H; Lackner C Liver Int; 2017 Apr; 37(4):600-610. PubMed ID: 27885796 [TBL] [Abstract][Full Text] [Related]
20. M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. Amidi F; French BA; Chung D; Halsted CH; Medici V; French SW Exp Mol Pathol; 2007 Dec; 83(3):296-300. PubMed ID: 17963745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]